Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Blaise F.D. Bourgeois, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Park EL, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Epilepsy Curr. 2018 Jul-Aug; 18(4):269-278. PMID: 30254528.
    Citations:    
  2. Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Llanas Park E, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2018 07 10; 91(2):82-90. PMID: 29898974.
    Citations: 1     Fields:    
  3. Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Llanas Park E, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2018 07 10; 91(2):74-81. PMID: 29898971.
    Citations: 1     Fields:    
  4. Bourgeois B, Ng BK, Latimer D, Stannard CR, Romeo L, Li X, Shepherd JA, Heymsfield SB. Clinically applicable optical imaging technology for body size and shape analysis: comparison of systems differing in design. Eur J Clin Nutr. 2017 11; 71(11):1329-1335. PMID: 28876331.
    Citations:    Fields:    Translation:Humans
  5. Vega C, Brenner LA, Madsen J, Bourgeois B, Waber DP, Boyer K. Lexical retrieval pre- and posttemporal lobe epilepsy surgery in a pediatric sample. Epilepsy Behav. 2015 Jan; 42:61-5. PMID: 25500357.
    Citations:    Fields:    Translation:Humans
  6. Bourgeois BF, Douglass LM, Sankar R. Lennox-Gastaut syndrome: a consensus approach to differential diagnosis. Epilepsia. 2014 Sep; 55 Suppl 4:4-9. PMID: 25284032.
    Citations: 8     Fields:    Translation:Humans
  7. Thome-Souza S, Kadish NE, Ramgopal S, Sánchez Fernández I, Bergin AM, Bolton J, Harini C, Libenson M, Olson H, Peters J, Poduri A, Rotenberg A, Takeoka M, Kothare SV, Kapur K, Bourgeois BF, Loddenkemper T. Safety and retention rate of rufinamide in 300 patients: a single pediatric epilepsy center experience. Epilepsia. 2014 Aug; 55(8):1235-44. PMID: 25070475.
    Citations: 2     Fields:    Translation:Humans
  8. Gonzalez-Heydrich J, Hsin O, Gumlak S, Kimball K, Rober A, Azeem MW, Hickory M, Mrakotsky C, Torres A, Mezzacappa E, Bourgeois B, Biederman J. Comparing stimulant effects in youth with ADHD symptoms and epilepsy. Epilepsy Behav. 2014 Jul; 36:102-7. PMID: 24907495.
    Citations: 2     Fields:    Translation:Humans
  9. Pinto AL, Lohani S, Bergin AM, Bourgeois BF, Black PM, Prabhu SP, Madsen JR, Takeoka M, Poduri A. Surgery for intractable epilepsy due to unilateral brain disease: a retrospective study comparing hemispherectomy techniques. Pediatr Neurol. 2014 Sep; 51(3):336-43. PMID: 25160539.
    Citations: 6     Fields:    Translation:Humans
  10. Klehm J, Thome-Souza S, Sánchez Fernández I, Bergin AM, Bolton J, Harini C, Kadish NE, Libenson M, Peters J, Poduri A, Rotenberg A, Takeoka M, Bourgeois B, Loddenkemper T. Clobazam: effect on frequency of seizures and safety profile in different subgroups of children with epilepsy. Pediatr Neurol. 2014 Jul; 51(1):60-6. PMID: 24830765.
    Citations: 4     Fields:    Translation:Humans
  11. Tanaka N, Peters JM, Prohl AK, Takaya S, Madsen JR, Bourgeois BF, Dworetzky BA, Hämäläinen MS, Stufflebeam SM. Clinical value of magnetoencephalographic spike propagation represented by spatiotemporal source analysis: correlation with surgical outcome. Epilepsy Res. 2014 Feb; 108(2):280-8. PMID: 24315019.
    Citations: 5     Fields:    Translation:Humans
  12. Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Guerreiro C, Kälviäinen R, Mattson R, French JA, Perucca E, Tomson T. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2013 Mar; 54(3):551-63. PMID: 23350722.
    Citations: 80     Fields:    Translation:Humans
  13. Bourgeois BF. Initiating antiepileptic drug treatment and characteristics of drugs. Handb Clin Neurol. 2013; 111:719-25. PMID: 23622219.
    Citations: 1     Fields:    Translation:Humans
  14. Dewolfe JL, Malow B, Huguenard J, Stickgold R, Bourgeois B, Holmes GL. Sleep and epilepsy: a summary of the 2011 merritt-putnam symposium. Epilepsy Curr. 2013 Jan; 13(1):42-9. PMID: 23447740.
    Citations: 5     
  15. Bourgeois BF, Goodkin HP. Efficacy of antiepileptic drugs in adults vs children: does one size fit all? Neurology. 2012 Oct 02; 79(14):1420-1. PMID: 22955137.
    Citations: 1     Fields:    Translation:Humans
  16. Tanaka N, Liu H, Reinsberger C, Madsen JR, Bourgeois BF, Dworetzky BA, Hämäläinen MS, Stufflebeam SM. Language lateralization represented by spatiotemporal mapping of magnetoencephalography. AJNR Am J Neuroradiol. 2013 Mar; 34(3):558-63. PMID: 22878013.
    Citations: 8     Fields:    Translation:Humans
  17. Vendrame M, Guilhoto LM, Loddenkemper T, Gregas M, Bourgeois BF, Kothare SV. Outcomes of epileptic spasms in patients aged less than 3 years: single-center United States experience. Pediatr Neurol. 2012 May; 46(5):276-80. PMID: 22520347.
    Citations: 4     Fields:    Translation:Humans
  18. Poduri A, Evrony GD, Cai X, Elhosary PC, Beroukhim R, Lehtinen MK, Hills LB, Heinzen EL, Hill A, Hill RS, Barry BJ, Bourgeois BF, Riviello JJ, Barkovich AJ, Black PM, Ligon KL, Walsh CA. Somatic activation of AKT3 causes hemispheric developmental brain malformations. Neuron. 2012 Apr 12; 74(1):41-8. PMID: 22500628.
    Citations: 108     Fields:    Translation:HumansCells
  19. Parvizi J, Le S, Foster BL, Bourgeois B, Riviello JJ, Prenger E, Saper C, Kerrigan JF. Gelastic epilepsy and hypothalamic hamartomas: neuroanatomical analysis of brain lesions in 100 patients. Brain. 2011 Oct; 134(Pt 10):2960-8. PMID: 21975589.
    Citations: 14     Fields:    Translation:Humans
  20. Waugh J, Prabhu SP, Bourgeois B, Kothare S. Clinical reasoning: a 16-year-old girl with fixed unilateral grimace. Neurology. 2011 Sep 13; 77(11):e61-4. PMID: 21911732.
    Citations:    Fields:    Translation:Humans
  21. Vendrame M, Kaleyias J, Loddenkemper T, Smith E, McClain C, Rockoff M, Manganaro S, McKenzie B, Gao L, Scott M, Bourgeois B, Kothare SV. Electroencephalogram monitoring during intracranial surgery for moyamoya disease. Pediatr Neurol. 2011 Jun; 44(6):427-32. PMID: 21555053.
    Citations: 3     Fields:    Translation:Humans
  22. Guilhoto LM, Loddenkemper T, Gooty VD, Rotenberg A, Takeoka M, Duffy FH, Coulter D, Urion D, Bourgeois BF, Kothare SV. Experience with lacosamide in a series of children with drug-resistant focal epilepsy. Pediatr Neurol. 2011 Jun; 44(6):414-9. PMID: 21555051.
    Citations: 10     Fields:    Translation:Humans
  23. Olson HE, Loddenkemper T, Vendrame M, Poduri A, Takeoka M, Bergin AM, Libenson MH, Duffy FH, Rotenberg A, Coulter D, Bourgeois BF, Kothare SV. Rufinamide for the treatment of epileptic spasms. Epilepsy Behav. 2011 Feb; 20(2):344-8. PMID: 21233024.
    Citations: 5     Fields:    Translation:Humans
  24. Guilhoto LM, Loddenkemper T, Vendrame M, Bergin A, Bourgeois BF, Kothare SV. Higher evening antiepileptic drug dose for nocturnal and early-morning seizures. Epilepsy Behav. 2011 Feb; 20(2):334-7. PMID: 21195032.
    Citations: 8     Fields:    Translation:Humans
  25. Benson LA, Maski KP, Kothare SV, Bourgeois BF. New onset epilepsy in Prader-Willi syndrome: semiology and literature review. Pediatr Neurol. 2010 Oct; 43(4):297-9. PMID: 20837313.
    Citations: 3     Fields:    Translation:Humans
  26. Vendrame M, Loddenkemper T, Gooty VD, Takeoka M, Rotenberg A, Bergin AM, Eksioglu YZ, Poduri A, Duffy FH, Libenson M, Bourgeois BF, Kothare SV. Experience with rufinamide in a pediatric population: a single center's experience. Pediatr Neurol. 2010 Sep; 43(3):155-8. PMID: 20691934.
    Citations: 6     Fields:    Translation:Humans
  27. Gonzalez-Heydrich J, Whitney J, Waber D, Forbes P, Hsin O, Faraone SV, Dodds A, Rao S, Mrakotsky C, Macmillan C, Demaso DR, de Moor C, Torres A, Bourgeois B, Biederman J. Adaptive phase I study of OROS methylphenidate treatment of attention deficit hyperactivity disorder with epilepsy. Epilepsy Behav. 2010 Jul; 18(3):229-37. PMID: 20493783.
    Citations: 14     Fields:    Translation:HumansCTClinical Trials
  28. Reinsberger C, Tanaka N, Cole AJ, Lee JW, Dworetzky BA, Bromfield EB, Hamiwka L, Bourgeois BF, Golby AJ, Madsen JR, Stufflebeam SM. Current dipole orientation and distribution of epileptiform activity correlates with cortical thinning in left mesiotemporal epilepsy. Neuroimage. 2010 Oct 01; 52(4):1238-42. PMID: 20472073.
    Citations: 2     Fields:    Translation:Humans
  29. Sarco DP, Bourgeois BF. The safety and tolerability of newer antiepileptic drugs in children and adolescents. CNS Drugs. 2010 May; 24(5):399-430. PMID: 20192278.
    Citations: 1     Fields:    Translation:Humans
  30. Tanaka N, Hämäläinen MS, Ahlfors SP, Liu H, Madsen JR, Bourgeois BF, Lee JW, Dworetzky BA, Belliveau JW, Stufflebeam SM. Propagation of epileptic spikes reconstructed from spatiotemporal magnetoencephalographic and electroencephalographic source analysis. Neuroimage. 2010 Mar; 50(1):217-22. PMID: 20006721.
    Citations: 15     Fields:    Translation:Humans
  31. Tanaka N, Thiele EA, Madsen JR, Bourgeois BF, Stufflebeam SM. Magnetoencephalographic analysis in patients with vagus nerve stimulator. Pediatr Neurol. 2009 Nov; 41(5):383-7. PMID: 19818944.
    Citations: 5     Fields:    Translation:Humans
  32. Rotenberg A, Bae EH, Muller PA, Riviello JJ, Bourgeois BF, Blum AS, Pascual-Leone A. In-session seizures during low-frequency repetitive transcranial magnetic stimulation in patients with epilepsy. Epilepsy Behav. 2009 Oct; 16(2):353-5. PMID: 19747883.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  33. Tanaka N, Cole AJ, von Pechmann D, Wakeman DG, Hämäläinen MS, Liu H, Madsen JR, Bourgeois BF, Stufflebeam SM. Dynamic statistical parametric mapping for analyzing ictal magnetoencephalographic spikes in patients with intractable frontal lobe epilepsy. Epilepsy Res. 2009 Aug; 85(2-3):279-86. PMID: 19394198.
    Citations: 12     Fields:    Translation:Humans
  34. Delgado-Escueta AV, Bourgeois BF. Debate: Does genetic information in humans help us treat patients? PRO--genetic information in humans helps us treat patients. CON--genetic information does not help at all. Epilepsia. 2008 Dec; 49 Suppl 9:13-24. PMID: 19087113.
    Citations: 7     Fields:    Translation:Humans
  35. Patsalos PN, Berry DJ, Bourgeois BF, Cloyd JC, Glauser TA, Johannessen SI, Leppik IE, Tomson T, Perucca E. Antiepileptic drugs--best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia. 2008 Jul; 49(7):1239-76. PMID: 18397299.
    Citations: 107     Fields:    Translation:Humans
  36. Bourgeois BF. Broader is better: the ranks of broad-spectrum antiepileptic drugs are growing. Neurology. 2007 Oct 30; 69(18):1734-6. PMID: 17967991.
    Citations: 1     Fields:    Translation:Humans
  37. Hara K, Lin FH, Camposano S, Foxe DM, Grant PE, Bourgeois BF, Ahlfors SP, Stufflebeam SM. Magnetoencephalographic mapping of interictal spike propagation: a technical and clinical report. AJNR Am J Neuroradiol. 2007 Sep; 28(8):1486-8. PMID: 17846196.
    Citations: 4     Fields:    Translation:Humans
  38. Gonzalez-Heydrich J, Dodds A, Whitney J, MacMillan C, Waber D, Faraone SV, Boyer K, Mrakotsky C, DeMaso D, Bourgeois B, Biederman J. Psychiatric disorders and behavioral characteristics of pediatric patients with both epilepsy and attention-deficit hyperactivity disorder. Epilepsy Behav. 2007 May; 10(3):384-8. PMID: 17368109.
    Citations: 7     Fields:    Translation:Humans
  39. Poduri A, Golja A, Takeoka M, Bourgeois BF, Connolly L, Riviello JJ. Focal cortical malformations can show asymmetrically higher uptake on interictal fluorine-18 fluorodeoxyglucose positron emission tomography (PET). J Child Neurol. 2007 Feb; 22(2):232-7. PMID: 17621491.
    Citations: 3     Fields:    Translation:Humans
  40. Hadjiloizou SM, Bourgeois BF. Antiepileptic drug treatment in children. Expert Rev Neurother. 2007 Feb; 7(2):179-93. PMID: 17286551.
    Citations: 4     Fields:    Translation:Humans
  41. Shoeb A, Bourgeois B, Treves S, Schachter SC, Guttag J. Impact of patient-specificity on seizure onset detection performance. Conf Proc IEEE Eng Med Biol Soc. 2007; 2007:4110-4. PMID: 18002906.
    Citations: 3     Fields:    Translation:Humans
  42. Jensen FE, Bourgeois BF. Randomized trial supports use of levetiracetam adjunctive therapy to treat partial seizures in children. Nat Clin Pract Neurol. 2006 Nov; 2(11):596-7. PMID: 17057745.
    Citations: 1     Fields:    
  43. Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Chadwick D, Guerreiro C, Kalviainen R, Mattson R, Perucca E, Tomson T. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2006 Jul; 47(7):1094-120. PMID: 16886973.
    Citations: 103     Fields:    Translation:Humans
  44. Tekgul H, Gauvreau K, Soul J, Murphy L, Robertson R, Stewart J, Volpe J, Bourgeois B, du Plessis AJ. The current etiologic profile and neurodevelopmental outcome of seizures in term newborn infants. Pediatrics. 2006 Apr; 117(4):1270-80. PMID: 16585324.
    Citations: 53     Fields:    Translation:Humans
  45. Knake S, Halgren E, Shiraishi H, Hara K, Hamer HM, Grant PE, Carr VA, Foxe D, Camposano S, Busa E, Witzel T, Hämäläinen MS, Ahlfors SP, Bromfield EB, Black PM, Bourgeois BF, Cole AJ, Cosgrove GR, Dworetzky BA, Madsen JR, Larsson PG, Schomer DL, Thiele EA, Dale AM, Rosen BR, Stufflebeam SM. The value of multichannel MEG and EEG in the presurgical evaluation of 70 epilepsy patients. Epilepsy Res. 2006 Apr; 69(1):80-6. PMID: 16516443.
    Citations: 26     Fields:    Translation:Humans
  46. Biton V, Bourgeois BF. Topiramate in patients with juvenile myoclonic epilepsy. Arch Neurol. 2005 Nov; 62(11):1705-8. PMID: 16286543.
    Citations: 8     Fields:    Translation:Humans
  47. Sazgar M, Bourgeois BF. Aggravation of epilepsy by antiepileptic drugs. Pediatr Neurol. 2005 Oct; 33(4):227-34. PMID: 16194719.
    Citations: 7     Fields:    Translation:Humans
  48. Bourgeois BF, D'Souza J. Long-term safety and tolerability of oxcarbazepine in children: a review of clinical experience. Epilepsy Behav. 2005 Nov; 7(3):375-82. PMID: 16176888.
    Citations: 5     Fields:    Translation:Humans
  49. Bourgeois B, Ferron Ch, Bordure P, Beauvillain de Montreuil C, Legent F. [Exploratory tympanotomy for suspected traumatic perilymphatic fistula]. Ann Otolaryngol Chir Cervicofac. 2005 Sep; 122(4):181-6. PMID: 16230938.
    Citations:    Fields:    Translation:Humans
  50. Poduri A, Golja A, Riviello JJ, Bourgeois BF, Duffy FH, Takeoka M. A distinct asymmetrical pattern of cortical malformation: large unilateral malformation of cortical development with contralateral periventricular nodular heterotopia in three pediatric cases. Epilepsia. 2005 Aug; 46(8):1317-21. PMID: 16060947.
    Citations: 1     Fields:    Translation:Humans
  51. Tekgul H, Bourgeois BF, Gauvreau K, Bergin AM. Electroencephalography in neonatal seizures: comparison of a reduced and a full 10/20 montage. Pediatr Neurol. 2005 Mar; 32(3):155-61. PMID: 15730894.
    Citations: 9     Fields:    Translation:Humans
  52. Shoeb A, Guttag J, Schachter S, Schomer D, Bourgeois B, Ted Treves S. Detecting seizure onset in the ambulatory setting: demonstrating feasibility. Conf Proc IEEE Eng Med Biol Soc. 2005; 2005:3546-50. PMID: 17280990.
    Citations: 2     Fields:    
  53. Bourgeois BF, Landau WM. Landau-Kleffner syndrome and temporal cortical volume reduction: cause or effect? Neurology. 2004 Oct 12; 63(7):1152-3. PMID: 15477529.
    Citations: 1     Fields:    Translation:Humans
  54. Shoeb A, Edwards H, Connolly J, Bourgeois B, Treves ST, Guttag J. Patient-specific seizure onset detection. Epilepsy Behav. 2004 Aug; 5(4):483-98. PMID: 15256184.
    Citations: 20     Fields:    Translation:Humans
  55. Wheless JW, Bourgeois BF. Choosing antiepileptic drugs for developmentally normal children with specific epilepsy syndromes and behavioral disorders. J Child Neurol. 2004 Aug; 19 Suppl 1:S39-48. PMID: 15526969.
    Citations:    Fields:    Translation:Humans
  56. Bourgeois BF. Determining the effects of antiepileptic drugs on cognitive function in pediatric patients with epilepsy. J Child Neurol. 2004 Aug; 19 Suppl 1:S15-24. PMID: 15526967.
    Citations: 9     Fields:    Translation:Humans
  57. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE, Sachdeo RC, Beydoun A, Glauser TA. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia. 2004 May; 45(5):410-23. PMID: 15101822.
    Citations: 17     Fields:    Translation:Humans
  58. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE, Sachdeo RC, Beydoun A, Glauser TA. Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia. 2004 May; 45(5):401-9. PMID: 15101821.
    Citations: 12     Fields:    Translation:Humans
  59. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE, Sachdeo RC, Beydoun A, Glauser TA. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2004 Apr 27; 62(8):1252-60. PMID: 15111659.
    Citations: 66     Fields:    Translation:Humans
  60. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE, Sachdeo RC, Beydoun A, Glauser TA. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2004 Apr 27; 62(8):1261-73. PMID: 15111660.
    Citations: 89     Fields:    Translation:Humans
  61. Lardizabal DV, Lüders HO, Hovinga CA, Bourgeois BF. Severe intoxication after phenytoin infusion: a preventable pharmacogenetic adverse reaction. Neurology. 2004 Jan 13; 62(1):161; author reply 161. PMID: 14727316.
    Citations: 1     Fields:    Translation:Humans
  62. Gonzalez-Heydrich J, Pandina GJ, Fleisher CA, Hsin O, Raches D, Bourgeois BF, Biederman J. No seizure exacerbation from risperidone in youth with comorbid epilepsy and psychiatric disorders: a case series. J Child Adolesc Psychopharmacol. 2004; 14(2):295-310. PMID: 15319026.
    Citations: 1     Fields:    Translation:Humans
  63. Shoeb A, Edwards H, Connolly J, Bourgeois B, Treves T, Guttag J. Patient-specific seizure onset detection. Conf Proc IEEE Eng Med Biol Soc. 2004; 2006:419-22. PMID: 17271701.
    Citations: 3     Fields:    
  64. Bourgeois BF. Chronic management of seizures in the syndromes of idiopathic generalized epilepsy. Epilepsia. 2003; 44 Suppl 2:27-32. PMID: 12752459.
    Citations: 2     Fields:    Translation:Humans
  65. Bourgeois BF. Reducing overtreatment. Epilepsy Res. 2002 Nov; 52(1):53-60. PMID: 12445960.
    Citations: 3     Fields:    Translation:Humans
  66. McKhann GM, Bourgeois BF, Goodman RR. Epilepsy surgery: indications, approaches, and results. Semin Neurol. 2002 Sep; 22(3):269-78. PMID: 12528052.
    Citations: 4     Fields:    Translation:HumansAnimals
  67. Menache CC, Bourgeois BF, Volpe JJ. Prognostic value of neonatal discontinuous EEG. Pediatr Neurol. 2002 Aug; 27(2):93-101. PMID: 12213608.
    Citations: 7     Fields:    Translation:Humans
  68. Bourgeois B. New dosages and formulations of AEDs for use in pediatric epilepsy. Neurology. 2002 Jun 25; 58(12 Suppl 7):S2-5. PMID: 12084860.
    Citations: 1     Fields:    Translation:Humans
  69. Bourgeois BF. Effect of Ketamine on Learning Impairment. To the Editor. Epilepsy Behav. 2002 Apr; 3(2):197. PMID: 12609424.
    Citations:    Fields:    
  70. Bourgeois BF. Differential cognitive effects of antiepileptic drugs. J Child Neurol. 2002 Feb; 17 Suppl 2:2S28-2S33. PMID: 11952034.
    Citations: 1     Fields:    Translation:Humans
  71. Raghavachari S, Kahana MJ, Rizzuto DS, Caplan JB, Kirschen MP, Bourgeois B, Madsen JR, Lisman JE. Gating of human theta oscillations by a working memory task. J Neurosci. 2001 May 01; 21(9):3175-83. PMID: 11312302.
    Citations: 147     Fields:    Translation:HumansCTClinical Trials
  72. Takeoka M, Holmes GL, Thiele E, Bourgeois BF, Helmers SL, Duffy FH, Riviello JJ. Topiramate and metabolic acidosis in pediatric epilepsy. Epilepsia. 2001 Mar; 42(3):387-92. PMID: 11442157.
    Citations: 13     Fields:    Translation:Humans
  73. Kerrigan JF, Shields WD, Nelson TY, Bluestone DL, Dodson WE, Bourgeois BF, Pellock JM, Morton LD, Monaghan EP. Ganaxolone for treating intractable infantile spasms: a multicenter, open-label, add-on trial. Epilepsy Res. 2000 Dec; 42(2-3):133-9. PMID: 11074186.
    Citations: 28     Fields:    Translation:HumansCTClinical Trials
  74. Robinson S, Park TS, Blackburn LB, Bourgeois BF, Arnold ST, Dodson WE. Transparahippocampal selective amygdalohippocampectomy in children and adolescents: efficacy of the procedure and cognitive morbidity in patients. J Neurosurg. 2000 Sep; 93(3):402-9. PMID: 10969937.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  75. Bourgeois BF. Drug treatment of benign focal epilepsies of childhood. Epilepsia. 2000 Aug; 41(8):1057-8. PMID: 10961639.
    Citations: 2     Fields:    Translation:Humans
  76. Schmidt D, Bourgeois B. A risk-benefit assessment of therapies for Lennox-Gastaut syndrome. Drug Saf. 2000 Jun; 22(6):467-77. PMID: 10877040.
    Citations: 19     Fields:    Translation:Humans
  77. Bourgeois BF. New antiepileptic drugs in children: which ones for which seizures? Clin Neuropharmacol. 2000 May-Jun; 23(3):119-32. PMID: 10895395.
    Citations: 1     Fields:    Translation:Humans
  78. Bourgeois BF. Pharmacokinetic properties of current antiepileptic drugs: what improvements are needed? Neurology. 2000; 55(11 Suppl 3):S11-6. PMID: 11147563.
    Citations: 6     Fields:    Translation:Humans
  79. Bourgeois BF. Pharmacokinetics and pharmacodynamics of topiramate. J Child Neurol. 2000; 15 Suppl 1:S27-30. PMID: 11218054.
    Citations: 5     Fields:    Translation:Humans
  80. Bourgeois BF. A retarded boy with seizures precipitated by stepping into the bath water. Semin Pediatr Neurol. 1999 Sep; 6(3):151-6; discussion 156-7. PMID: 10522331.
    Citations: 1     Fields:    Translation:HumansCells
  81. Wad N, Bourgeois B, Krämer G. Serum protein binding of desmethyl-methsuximide. Clin Neuropharmacol. 1999 Jul-Aug; 22(4):239-40. PMID: 10442255.
    Citations:    Fields:    Translation:HumansCells
  82. Bourgeois BF. Pharmacokinetics and metabolism of topiramate. Drugs Today (Barc). 1999 Jan; 35(1):43-8. PMID: 12973408.
    Citations: 4     Fields:    
  83. Lee BC, Schmidt RE, Hatfield GA, Bourgeois B, Park TS. MRI of focal cortical dysplasia. Neuroradiology. 1998 Oct; 40(10):675-83. PMID: 9833901.
    Citations: 4     Fields:    Translation:Humans
  84. Bourgeois BF. Antiepileptic drugs, learning, and behavior in childhood epilepsy. Epilepsia. 1998 Sep; 39(9):913-21. PMID: 9738670.
    Citations: 13     Fields:    Translation:Humans
  85. Bourgeois BF. New antiepileptic drugs. Arch Neurol. 1998 Sep; 55(9):1181-3. PMID: 9740111.
    Citations: 3     Fields:    Translation:Humans
  86. Bourgeois BF. Temporal lobe epilepsy in infants and children. Brain Dev. 1998 Apr; 20(3):135-41. PMID: 9628189.
    Citations: 8     Fields:    Translation:Humans
  87. Kanner AM, Bourgeois BF, Hasegawa H, Hutson P. Rapid switchover to carbamazepine using pharmacokinetic parameters. Epilepsia. 1998 Feb; 39(2):194-200. PMID: 9578000.
    Citations:    Fields:    Translation:Humans
  88. Bourgeois BF. New antiepileptic drugs. Curr Opin Pediatr. 1996 Dec; 8(6):543-8. PMID: 9018437.
    Citations: 2     Fields:    Translation:Humans
  89. Bourgeois B. The relationship between sleep and epilepsy in children. Semin Pediatr Neurol. 1996 Mar; 3(1):29-35. PMID: 8795839.
    Citations: 6     Fields:    Translation:Humans
  90. Bourgeois BF. Drug interaction profile of topiramate. Epilepsia. 1996; 37 Suppl 2:S14-S17. PMID: 8641241.
    Citations: 4     Fields:    Translation:Humans
  91. Bourgeois B. Clinical use of drugs useful in the treatment of atonic seizures. Adv Neurol. 1995; 67:361-7. PMID: 8848980.
    Citations:    Fields:    Translation:Humans
  92. Bourgeois BF. Important pharmacokinetic properties of antiepileptic drugs. Epilepsia. 1995; 36 Suppl 5:S1-7. PMID: 8806398.
    Citations: 2     Fields:    Translation:Humans
  93. Bourgeois BF. Antiepileptic drugs in pediatric practice. Epilepsia. 1995; 36 Suppl 2:S34-45. PMID: 8784213.
    Citations:    Fields:    Translation:Humans
  94. Bourgeois B. [Sodium valproate and cognitive function]. Praxis (Bern 1994). 1994 Oct 04; 83(40):1122-5. PMID: 7939083.
    Citations:    Fields:    Translation:Humans
  95. Dodson WE, Bourgeois BF. Pharmacology and therapeutic aspects of antiepileptic drugs in pediatrics. J Child Neurol. 1994 Oct; 9 Suppl 2:1-7. PMID: 7806779.
    Citations: 2     Fields:    Translation:Humans
  96. Chez MG, Bourgeois BF, Pippenger CE, Knowles WD. Pharmacodynamic interactions between phenytoin and valproate: individual and combined antiepileptic and neurotoxic actions in mice. Clin Neuropharmacol. 1994 Feb; 17(1):32-7. PMID: 8149357.
    Citations: 3     Fields:    Translation:Animals
  97. Schäffler L, Bourgeois BF, Lüders HO. Rapid reversibility of autoinduction of carbamazepine metabolism after temporary discontinuation. Epilepsia. 1994 Jan-Feb; 35(1):195-8. PMID: 8112245.
    Citations: 1     Fields:    Translation:Humans
  98. Adusumalli VE, Wichmann JK, Kucharczyk N, Kamin M, Sofia RD, French J, Sperling M, Bourgeois B, Devinsky O, Dreifuss FE, et al. Drug concentrations in human brain tissue samples from epileptic patients treated with felbamate. Drug Metab Dispos. 1994 Jan-Feb; 22(1):168-70. PMID: 8149879.
    Citations: 2     Fields:    Translation:Humans
  99. Bourgeois BF. Felbamate in the treatment of partial-onset seizures. Epilepsia. 1994; 35 Suppl 5:S58-61. PMID: 8039474.
    Citations:    Fields:    Translation:Humans
  100. Bourgeois BF. Pharmacologic intervention and treatment of childhood seizure disorders: relative efficacy and safety of antiepileptic drugs. Epilepsia. 1994; 35 Suppl 2:S18-23. PMID: 8275977.
    Citations:    Fields:    Translation:HumansAnimals
  101. Wyllie E, Chee M, Granström ML, DelGiudice E, Estes M, Comair Y, Pizzi M, Kotagal P, Bourgeois B, Lüders H. Temporal lobe epilepsy in early childhood. Epilepsia. 1993 Sep-Oct; 34(5):859-68. PMID: 8404738.
    Citations: 8     Fields:    Translation:Humans
  102. Bourgeois BF. Clinical aspects of epilepsy including diagnosis, management, pharmacotherapy, and surgery. Curr Opin Neurol Neurosurg. 1993 Apr; 6(2):233-9. PMID: 8481566.
    Citations:    Fields:    Translation:Humans
  103. Bourgeois B, Leppik IE, Sackellares JC, Laxer K, Lesser R, Messenheimer JA, Kramer LD, Kamin M, Rosenberg A. Felbamate: a double-blind controlled trial in patients undergoing presurgical evaluation of partial seizures. Neurology. 1993 Apr; 43(4):693-6. PMID: 8469324.
    Citations: 14     Fields:    Translation:HumansCTClinical Trials
  104. Bourgeois BF. Childhood epilepsy: pharmacological considerations. Acta Neurol Scand Suppl. 1992; 140:23-7. PMID: 1441908.
    Citations:    Fields:    Translation:Humans
  105. Bourgeois BF. Relationship between anticonvulsant drugs and learning disabilities. Semin Neurol. 1991 Mar; 11(1):14-9. PMID: 2034913.
    Citations:    Fields:    Translation:Humans
  106. Lüders H, Wyllie E, Rothner DA, Bourgeois B, Kotagal P. Surgery of localization related epilepsies in children. Brain Dev. 1989; 11(2):98-101. PMID: 2653076.
    Citations:    Fields:    Translation:Humans
  107. Bourgeois BF. The rational use of antiepileptic drugs in children. Cleve Clin J Med. 1989; 56 Suppl Pt 2:S248-53. PMID: 2659216.
    Citations:    Fields:    Translation:Humans
  108. Bourgeois BF. Anticonvulsant potency and neurotoxicity of valproate alone and in combination with carbamazepine or phenobarbital. Clin Neuropharmacol. 1988 Aug; 11(4):348-59. PMID: 3145137.
    Citations: 4     Fields:    Translation:Animals
  109. Bourgeois BF, Wad N. Combined administration of carbamazepine and phenobarbital: effect on anticonvulsant activity and neurotoxicity. Epilepsia. 1988 Jul-Aug; 29(4):482-7. PMID: 3391152.
    Citations: 2     Fields:    Translation:Animals
  110. Bourgeois BF. Pharmacologic interactions between valproate and other drugs. Am J Med. 1988 Jan 25; 84(1A):29-33. PMID: 3146222.
    Citations: 4     Fields:    Translation:Humans
  111. Bourgeois BF. Problems of combination drug therapy in children. Epilepsia. 1988; 29 Suppl 3:S20-4. PMID: 3066617.
    Citations: 1     Fields:    Translation:Humans
  112. Issakainen J, Bourgeois BF. Bioavailability of sodium valproate suppositories during repeated administration at steady state in epileptic children. Eur J Pediatr. 1987 Jul; 146(4):404-7. PMID: 3115782.
    Citations: 3     Fields:    Translation:Humans
  113. Bourgeois B, Beaumanoir A, Blajev B, de la Cruz N, Despland PA, Egli M, Geudelin B, Kaspar U, Ketz E, Kronauer C, et al. Monotherapy with valproate in primary generalized epilepsies. Epilepsia. 1987; 28 Suppl 2:S8-11. PMID: 3121293.
    Citations: 8     Fields:    Translation:HumansCTClinical Trials
  114. Bourgeois BF. Antiepileptic drug combinations and experimental background: the case of phenobarbital and phenytoin. Naunyn Schmiedebergs Arch Pharmacol. 1986 Aug; 333(4):406-11. PMID: 3774019.
    Citations: 3     Fields:    Translation:Animals
  115. Bourgeois BF, Küpfer A, Wad N, Egli M. Pharmacokinetics of R-enantiomeric normephenytoin during chronic administration in epileptic patients. Epilepsia. 1986 Jul-Aug; 27(4):412-8. PMID: 3720699.
    Citations:    Fields:    Translation:Humans
  116. Bourgeois BF, Wad N. Michaelis-Menten kinetics and the steady-state serum phenytoin/hydroxyphenytoin ratio. Ther Drug Monit. 1985; 7(4):405-10. PMID: 4082240.
    Citations:    Fields:    Translation:Humans
  117. Bourgeois BF, Wad N. Carbamazepine-10,11-diol steady-state serum levels and renal excretion during carbamazepine therapy in adults and children. Ther Drug Monit. 1984; 6(3):259-65. PMID: 6506133.
    Citations: 15     Fields:    Translation:Humans
  118. Bourgeois BF, Prensky AL, Palkes HS, Talent BK, Busch SG. Intelligence in epilepsy: a prospective study in children. Ann Neurol. 1983 Oct; 14(4):438-44. PMID: 6416142.
    Citations: 30     Fields:    Translation:Humans
  119. Bourgeois BF, Dodson WE, Ferrendelli JA. Potentiation of the antiepileptic activity of phenobarbital by nicotinamide. Epilepsia. 1983 Apr; 24(2):238-44. PMID: 6219870.
    Citations: 1     Fields:    Translation:Animals
  120. Bourgeois BF, Dodson WE, Ferrendelli JA. Primidone, phenobarbital, and PEMA: I. Seizure protection, neurotoxicity, and therapeutic index of individual compounds in mice. Neurology. 1983 Mar; 33(3):283-90. PMID: 6681871.
    Citations: 1     Fields:    Translation:Animals
  121. Bourgeois BF, Dodson WE, Ferrendelli JA. Primidone, phenobarbital, and PEMA: II. Seizure protection, neurotoxicity, and therapeutic index of varying combinations in mice. Neurology. 1983 Mar; 33(3):291-5. PMID: 6681872.
    Citations: 3     Fields:    Translation:Animals
  122. Bourgeois BF, Dodson WE. Phenytoin elimination in newborns. Neurology. 1983 Feb; 33(2):173-8. PMID: 6681658.
    Citations: 5     Fields:    Translation:Humans
  123. Dodson WE, Bourgeois BF, Ferrendelli JA. Phenobarbital and phenytoin in neonatal seizures. Neurology. 1982 Dec; 32(12):1405-6. PMID: 6890651.
    Citations:    Fields:    Translation:Humans
  124. Bourgeois BF, Dodson WE, Ferrendelli JA. Isoniazid and other drugs. Pediatrics. 1982 Nov; 70(5):824-5. PMID: 7133834.
    Citations:    Fields:    Translation:Humans
  125. Bourgeois BF, Dodson WE, Ferrendelli JA. Interactions between primidone, carbamazepine, and nicotinamide. Neurology. 1982 Oct; 32(10):1122-26. PMID: 6214728.
    Citations: 3     Fields:    Translation:HumansAnimals
  126. Bourgeois BF, Donath A, Paunier L, Rouge JC. Effects of cardiac surgery on renal function in children. J Thorac Cardiovasc Surg. 1979 Feb; 77(2):283-6. PMID: 762969.
    Citations: 1     Fields:    Translation:Humans
  127. Renier JC, Bregeon C, Bonnette C, Boasson M, Bernat M, Basle M, Besson J, Wellinger C, Bourgeois B, Teisseire N. [Evolution of patients with rheumatoid arthritis treated with immunosuppressive agents between 1965 and 1973]. Rev Rhum Mal Osteoartic. 1978 Jul-Sep; 45(7-9):453-61. PMID: 725461.
    Citations: 3     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Bourgeois's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (312)
Explore
_
Co-Authors (59)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.